NZ Medical Device Company Chitogel Ltd Secures US$6.58M Investment From US Based Investor To Drive US Sales Expansion

The investment is aimed at driving the expansion and growth of Chitogel’s first-to-market hydrogel product for post-operative use following endoscopic sinus surgery.